Physician profile
Anthony Salvo
NPI 1568473346
$2,762.61
in general payments reported to CMS, 2019-2025
10 companies · $521 in 2025
The $521 reported for 2025 was more than what 81% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $399 · 2022: $75.97 · 2023: $895 · 2024: $871 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,287.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $1,076.34 | 2021-2025 | Durolane, Durolane, Xcell |
| Depuy Synthes Sales INC. | $449.46 | 2021-2025 | Monovisc |
| Gotham Surgical Solutions & Devices, INC. | $397.71 | 2022-2024 | |
| Si-Bone, INC. | $274.33 | 2021-2023 | |
| Stryker Corporation | $164.79 | 2021-2024 | Mako |
| Endo Pharmaceuticals INC. | $150.00 | 2024 | Xiaflex |
| Smith+Nephew, INC. | $149.42 | 2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Ferring Pharmaceuticals INC. | $46.34 | 2021 | |
| Horizon Therapeutics Plc | $27.54 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $26.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Salvo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.